Advanced AI Based Retinal Screening with Instant Results
New York-Tel Aviv based digital health company, AEYE Health, has developed an AI-based retinal screening system that provides analysis and diagnostic results within 60 seconds.
Retinal diseases such as diabetic retinopathy (DR), glaucoma, macular degeneration and hypertensive retinopathy are becoming a pandemic. Over a billion people worldwide, and over 75 million people in the US, are at high risk for loss of sight and require an annual retinal check.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, introduced its Rapid Equipment Deployment Kit for ICU ramp-ups, allowing doctors, nurses, technicians and hospital staff to quickly support critical care patient monitoring capabilities during the COVID-19 pandemic. 
A consortium of NHS trusts around the south coast of England has signed its second deal this year with imaging technology provider Sectra, in a move that is expected to advance how hospitals share and access important diagnostic imaging. A new shared multimedia archive will also allow the trusts to accelerate ambitions for initiatives including artificial intelligence. 
Since the beginning of the COVID-19 pandemic, Allscripts (NASDAQ: MDRX) and its clients have taken significant actions to ensure effective care delivery in the communities they serve. With unwavering dedication to patient health, caregivers from both large hospital systems and independent physician practices around the world continue to excel in the face of the unprecedented crisis to help manage their patients and combat the spread of the virus.